Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phase I study of vorinostat in combination with standard <scp>CHOP</scp> in patients with newly diagnosed peripheral T‐cell lymphoma

17 Apr 2013

Abstract excerpt

The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Histone Deacetylase Inhibitors Research
Share to Lymphoma Diagnosis and Treatment
Share to Viral-associated cancers and disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23590726
DOI: 10.1111/bjh.12326

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phase I study of vorinostat in combination with standard <scp>CHOP</scp> in patients with newly diagnosed peripheral T‐cell lymphomaPMID 23590726Read ↗

A multi‐centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T‐prolymphocytic leukaemia or mantle cell lymphomaSemantic proximity Read ↗

Idelalisib-rituximab induces durable remissions in TP53 disrupted B-PLL but results in significant toxicity: updated results of the UK-wide compassionate use programme.Semantic proximity Read ↗

Drug therapy for double-hit lymphomaSemantic proximity Read ↗

[Recent advance in peripheral T-cell lymphoma, not otherwise specified].Semantic proximity Read ↗

Peripheral T-Cell Lymphoma, Hemophagocytic Lymphohistiocytosis, and XIAP Gene Mutations: Getting the Treatment Right!Semantic proximity Read ↗

Anti-CD7 allogeneic WU-CART-007 in patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma: a phase 1/2 trialSemantic proximity Read ↗

An overview on anti-tubulin agents for the treatment of lymphoma patientsSemantic proximity Read ↗

<scp><i>MYD88</i></scp> somatic mutations in <scp>MALT</scp> lymphomasSemantic proximity Read ↗

Real-world experience of combined treatment with azacitidine and romidepsin in patients with peripheral T-cell lymphomaSemantic proximity Read ↗

Emerging strategies in peripheral T-cell lymphoma.Semantic proximity Read ↗

CHOP is insufficient for newly-diagnosed subcutaneous panniculitis-like T-cell lymphoma patients: A retrospective study of 32 patients in ChinaSemantic proximity Read ↗

WITHDRAWN: High-throughput preclinical screening of CD123 scFv to design 3rd generation of CAR T-cell in the treatment of BPDCN patientSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.